What clinical trials are available for pancreatic cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Clinical Trials for Pancreatic Cancer
Clinical trials are an important part of pancreatic cancer treatment, and I want to help you understand what's available and how to find them.
Why Clinical Trials Matter for Pancreatic Cancer
According to Let's Win Pancreatic Cancer, clinical trials are particularly important because current standard treatments often aren't effective long-term. Since pancreatic cancer is so challenging to treat, participating in a clinical trial may offer access to cutting-edge treatments that could work better for your specific situation.
Here's an important concept: clinical trials don't mean you're giving up standard care. As one oncologist explains, think of it as "standard of care plus" — you'll still receive the best current treatments, but may also get access to newer approaches being tested.
Types of Trials Currently Available
Based on recent research updates, here are the main categories of pancreatic cancer trials:
1. Targeted Therapy Trials (Mutation-Based)
- KRAS-targeted drugs: According to Dr. [removed] Strickler's presentation on pancreatic cancer advances, KRAS mutations drive about 87% of pancreatic cancers. New drugs like RMC-6236 are being tested in phase III trials to target these mutations specifically
- BRCA mutation trials: For patients with BRCA1, BRCA2, or PALB2 mutations, PARP inhibitors (like olaparib) are FDA-approved options
- Basket trials: These enroll patients with different cancer types but the same genetic mutation (like NTRK, ROS1, or ALK mutations)
2. Immunotherapy Trials
- Trials combining chemotherapy with immunotherapy agents
- Vaccine-based approaches (like GVAX) being tested in combination with other drugs
- Phase IIb/III trials testing immunotherapy added to standard chemotherapy
3. Chemotherapy Combination Trials
- NALIRIFOX: FDA-approved combination of irinotecan liposome (ONIVYDE) with oxaliplatin, fluorouracil, and leucovorin for first-line metastatic disease
- Sequential chemotherapy approaches combining FOLFIRINOX with gemcitabine/nab-paclitaxel
4. Radiation + Chemotherapy Trials
- Trials using proton beam radiation combined with capecitabine (Xeloda) to make borderline resectable tumors surgically removable
- SBRT (stereotactic body radiation therapy) studies for locally advanced disease
5. Supportive Care Trials
- Cachexia treatment: Ponsegromab (Pfizer) is being tested to address cancer-related weight loss and muscle loss, which affects quality of life
6. Biomarker-Based Trials
- The PASS-01 study uses organoid technology and molecular profiling to match patients with treatments based on their tumor's genetic fingerprint
- Trials focusing on pancreatic cancer subtypes (basal-like vs. classical)
How to Find Clinical Trials
Let's Win Pancreatic Cancer recommends several resources:
- Let's Win Trial Finder — A specialized tool that lets you search by disease stage, location, and other factors
- ClinicalTrials.gov — The National Institutes of Health database with detailed information
- Talk to your oncologist — Ask specifically: "Are there any clinical trials available for my stage and type of pancreatic cancer?"
- Get a second opinion — Other oncologists may be aware of trials your current doctor hasn't mentioned
Important Things to Know About Trials
✅ You keep standard care: Even in the control group, you receive current best treatment
✅ Safety monitoring: Trials are reviewed by strict regulatory boards that monitor for safety
✅ Costs are covered: Treatment costs and special tests are covered; some trials cover travel
✅ Better monitoring: Trial participants often receive more frequent check-ups and closer attention
✅ Early access: You may get access to promising new treatments years before FDA approval
Questions to Ask Your Doctor
- "Are there any clinical trials that match my cancer stage and genetic profile?"
- "Have you done molecular profiling on my tumor? Can I see the report?" (This is important — keep a copy with you)
- "What are the pros and cons of a trial versus standard treatment for my situation?"
- "How often would I need to visit the clinic, and what extra tests would be involved?"
- "Are there trials available now, or should I wait until after my first treatment?"
A Note on Timing
According to Let's Win Pancreatic Cancer, many patients think of trials as a "last resort," but for pancreatic cancer specifically, trials should be considered from the very beginning of treatment. Because this disease is so aggressive, getting access to cutting-edge treatments early may offer your best chance at better outcomes.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with clinical trials for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ